SCHEMBL740412

SCHEMBL740412

CCCCOc1cscc1OCCCC

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
LTA4H P09960 4/20 0.39
NR5A1 Q13285 1/20 0.38
MCHR1 Q99705 1/20 0.37
TLR8 Q9NR97 1/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
GLA P06280 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP19A1 P11511 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21359793 0.95 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL27847176 0.95 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6
Ethylene SCHEMBL29270268 0.95 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL9510356 0.93 NR5A1 (0.47) CYP1A2CYP2C9CYP2C19CYP3A4LTA4H
SCHEMBL9642637 0.93 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19CYP3A4LTA4H
SCHEMBL9298158 0.91 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL2744960 0.91 NR5A1 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4LTA4H
SCHEMBL738622 0.91 NR5A1 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4LTA4H
SCHEMBL741426 0.91 NR5A1 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4LTA4H
SCHEMBL2745290 0.91 NR5A1 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 505 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11915838-B2 Self-healing and stretchable polymeric compositions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 US claimed
US-20210375501-A1 SELF-HEALING AND STRETCHABLE POLYMERIC COMPOSITIONS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 2021-12-02 US claimed
WO-2020244608-A1 THIOPHENE ETHYNYL POLYMER CAPABLE OF ORDERED SUPERASSEMBLY WITH CARBON NANOTUBE AND PREPARATION METHOD THEREFOR 复旦大学 2020-12-10 WO claimed
CN-110194831-A It can be with the thiophene ethynyl polymer and preparation method of the orderly super group dress of carbon nanotube 复旦大学 2019-09-03 CN claimed
CN-122071617-A Aqueous coating agent and laminate 尤尼吉可株式会社 2026-05-22 CN disclosed
EP-4737520-A1 CONDUCTIVE COMPOSITE DISPERSION LIQUID AND METHOD FOR PRODUCING SAME, CAPACITOR AND METHOD FOR PRODUCING SAME, AND CONDUCTIVE MULTILAYER BODY AND METHOD FOR PRODUCING SAME Shin-Etsu Polymer Co., Ltd. (JP) 2026-05-06 EP disclosed
US-12527506-B2 Conductive composition, biomedical electrode, and biomedical sensor NITTO DENKO CORPORATION (JP) 2026-01-20 US disclosed
EP-4640769-A1 CONDUCTIVE POLYMER-CONTAINING DISPERSION, SOLID ELECTROLYTE CAPACITOR, AND PRODUCTION METHOD FOR SAME Resonac Corporation (JP) 2025-10-29 EP disclosed
US-12444322-B2 Simulated blood vessel and ulcer model using same DENKA COMPANY LIMITED (JP) 2025-10-14 US disclosed
EP-4338921-B1 SIMULATED BLOOD VESSEL AND ULCER MODEL USING SAME DENKA COMPANY LTD (JP) 2025-10-08 EP disclosed
US-20250304801-A1 CONDUCTIVE COMPOSITION AND PRODUCTION METHOD THEREFOR, AND WATER-SOLUBLE POLYMER AND PRODUCTION METHOD THEREFOR MITSUBISHI CHEMICAL CORPORATION (JP) 2025-10-02 US disclosed
US-12415930-B2 Conductive polymer composition, substrate, and method for producing substrate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-16 US disclosed
US-20020160282-A1 Design and synthesis of advanced NLO materials for electro-optic applications LIGHTWAVE LOGIC, INC. 2002-10-31 US disclosed
EP-1224503-A1 LIQUID CRYSTAL ALIGNMENT LAYER Agfa-Gevaert (BE) 2002-07-24 EP disclosed
WO-2002014305-A2 DESIGN AND SYNTHESIS OF ADVANCED NLO MATERIALS FOR ELECTRO-OPTIC APPLICATIONS LUMERA CORPORATION (US) 2002-02-21 WO disclosed
WO-2001029611-A1 LIQUID CRYSTAL ALIGNMENT LAYER AGFA-GEVAERT (BE) 2001-04-26 WO disclosed
EP-0328984-B1 PROCESS FOR THE PREPARATON OF THIOPHENE ETHERS HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-23 EP disclosed
US-4931568-A REACTING C1-C3 ALYKYLOXYTHIOPHENES WITH ALCOHOL; MONOMERS FOR ELECTROCONDUCTIVE POLYMERS HOECHST AKTIENGESELLSCHAFT (DE) 1990-06-05 US disclosed
CN-1035291-A The preparation method of thiophenethers HOECHST AG (DE) 1989-09-06 CN disclosed
EP-0328984-A1 Process for the preparaton of thiophene ethers HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160282-A1 Design and synthesis of advanced NLO materials for electro-optic applications ENO1, EMD, EFNA1 CYP1A2 3395/4885CYP2C9 3313/4885CYP2C19 3469/4885
US-12527506-B2 Conductive composition, biomedical electrode, and biomedical sensor TNNT2, PRNP, TNNI3 CYP1A2 588/4885CYP2C9 771/4885CYP2C19 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.